Search results
Results from the WOW.Com Content Network
The NHS Breast Screening Programme is supporting a research study trial to assess the risks (i.e. the chances of being diagnosed and treated for a non-life-threatening cancer) and benefits (i.e. the chances of saving life) in women aged 47 to 49 and 71 to 73 (Public Health England 2017).
Jewish populations, and particularly the large Ashkenazi Jewish population, are ideal for such research studies, because they exhibit a high degree of endogamy, and at the same time are a large group. Jewish populations are overwhelmingly urban and are concentrated near biomedical centers where such research has been carried out.
Three mutations in BRCA1 have been reported to account for the majority of Ashkenazi Jewish patients with inherited BRCA1-related breast and/or ovarian cancer: 185delAG, 188del11 and 5382insC in the BRCA1 gene.
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
The programme was established in October 2002 following several Department of Health reports on IT Strategies for the NHS, and on 1 April 2005 a new agency called NHS Connecting for Health (CfH) was formed to deliver the programme. [13] CfH absorbed both staff and workstreams from the abolished NHS Information Authority, the organisation it ...
The NHS e-Referral Service (ERS) is an electronic referral system developed for the Health and Social Care Information Centre by IT consultancy BJSS. It is used by NHS England and it replaced the Choose and Book service on 15 June 2015. [ 1 ]
Jewish Genealogy-DNA Tests. Lauren Gilbert, a senior manager at the Center for Jewish History (CJH), participate in a global online conference to launch genealogy testing for Holocaust survivors ...